MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5
Authors
Keywords
miR-22, Atherosclerosis, Inflammation, IRF5, Macrophage
Journal
EXPERIMENTAL CELL RESEARCH
Volume 409, Issue 2, Pages 112922
Publisher
Elsevier BV
Online
2021-11-14
DOI
10.1016/j.yexcr.2021.112922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy
- (2021) Runze Wang et al. Frontiers in Cell and Developmental Biology
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation
- (2020) Alastair L. Corbin et al. Science Immunology
- miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
- (2020) Jinchun Cong et al. Cancer Management and Research
- Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development
- (2020) Monika Gjorgjieva et al. Journal of Personalized Medicine
- MiR‐22 modulates the expression of lipogenesis‐related genes and promotes hepatic steatosis in vitro
- (2020) Zhuo Yang et al. FEBS Open Bio
- Irf5 deficiency in myeloid cells prevents necrotizing enterocolitis by inhibiting M1 macrophage polarization
- (2019) Jia Wei et al. Mucosal Immunology
- miR-22 in Smooth Muscle Cells
- (2018) Zhan-Peng Huang et al. CIRCULATION
- miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation
- (2017) Feng Yang et al. CIRCULATION
- Macrophage Phenotype and Function in Different Stages of Atherosclerosis
- (2016) Ira Tabas et al. CIRCULATION RESEARCH
- miR-22-5p revealed as a potential biomarker involved in the acute phase of myocardial infarction via profiling of circulating microRNAs
- (2016) Agata Maciejak et al. Molecular Medicine Reports
- IRF5 Deficiency Ameliorates Lupus but Promotes Atherosclerosis and Metabolic Dysfunction in a Mouse Model of Lupus-Associated Atherosclerosis
- (2015) Amanda A. Watkins et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-specific regulatory mechanisms in atherosclerosis
- (2015) Maliheh Nazari-Jahantigh et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MicroRNA regulatory networks in human adipose tissue and obesity
- (2015) Peter Arner et al. Nature Reviews Endocrinology
- miR-22 in cardiac remodeling and disease
- (2014) Zhan-Peng Huang et al. TRENDS IN CARDIOVASCULAR MEDICINE
- miR-22 in tumorigenesis
- (2013) Su Jung Song et al. CELL CYCLE
- Pivotal role of microRNAs in cardiac physiology and heart failure
- (2013) André M. Leite-Moreira et al. DRUG DISCOVERY TODAY
- MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
- (2013) Daniel Quiat et al. JOURNAL OF CLINICAL INVESTIGATION
- IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
- (2011) Thomas Krausgruber et al. NATURE IMMUNOLOGY
- The Role of Endoplasmic Reticulum Stress in the Progression of Atherosclerosis
- (2010) Ira Tabas CIRCULATION RESEARCH
- Macrophage Diversity and Polarization in Atherosclerosis
- (2009) Alberto Mantovani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
- (2008) Vijay Divakaran et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started